A response to the ACP-ASIM position paper on pharmacist scope of practice

American Journal of Health-System Pharmacy

Volumn 59, Issue 15, 2002, Pages 1453-1456

  Zed, Peter J ^a   Loewen, Peter S ^a   Jewesson, Peter J ^a  

^a Clinical Services Unit Pharmaceutical Sciences Vancouver Acute Canada   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; HEALTH CARE DELIVERY; NOTE; PHARMACIST; PHARMACY; PHYSICIAN; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; RESPONSIBILITY;

EID: 0036683720     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/59.15.1453     Document Type: Note

References (23)

1. A prospective randomized trial to assess the cost impact of pharmacist-initiated interventions
2. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit
3. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: Results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study
4. Pharmacist scope of practice
5. Guidelines for therapeutic interchange
6. Depression of elderly outpatients: Primary care physicians' attitudes and practice patterns
7. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy
8. Prevalence of potentially inappropriate long term prescribing in general practice in the United Kingdom, 1980-95: Systematic literature review
9. Quality assurance for drug prescribing
10. Prescribing rights. Adequate training required
11. Clinical pharmacology and therapeutics in undergraduate medical education in the UK: Current status
12. Nurse prescribing. Advantages, disadvantages and future implications
13. Nurse prescribing. We are being manipulated into extending our role to fill the gaps left by medicine
14. Drug-related morbidity and mortality: Updating the cost-of-illness model
15. Drug-related morbidity and mortality. A cost of illness study
16. Adverse drug events in hospitalized patients: Excess length of stay, extra costs and attributable mortality
17. The costs of adverse events in hospitalized patients
18. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies
19. Medication misadventures resulting in emergency department visits at an HMO medical center
20. Frequency and cost of serious adverse drug reactions in a department of general medicine
21. Medication-related visits to the emergency department: A prospective study
22. Polypharmacy, adverse drug-related events, and potential adverse drug reactions in elderly patients presenting to the emergency department